Show simple item record

dc.contributor.authorParra, Solange
dc.contributor.authorPetermann-Rocha, Fanny
dc.contributor.authorBoonpor, Jirapitcha
dc.contributor.authorGray, S.R.
dc.contributor.authorPell, J.P.
dc.contributor.authorCelis-Morales, Carlos
dc.contributor.authorHo, Frederick
dc.date.accessioned2021-12-21T13:11:27Z
dc.date.available2021-12-21T13:11:27Z
dc.date.issued2021
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/3647
dc.description.abstractBackground: Body mass index (BMI) and waist circumference (WC) are measures of general and central obesity, respectively, and both have been shown to be associated with cancer. However, there is insufficient evidence of their combined association with the risk of cancer. Objectives: This study aimed to investigate the associations of combinations of BMI and WC with cancer at 22 sites. Methods: A total of 386,101 (54.5% women) UK Biobank participants aged from 37 to 73 y were included. The outcomes were incidence of and mortality from cancer at 22 sites. Participants were categorized as normal weight (BMI 18.5–24.9) or overweight (including obese, BMI ≥ 25) and as normal WC or centrally obese (WC ≥ 94 cm for men and ≥80 cm for women). Four mutually exclusive groups were derived: 1) normal weight without central obesity, 2) normal weight with central obesity, 3) overweight without central obesity, and 4) overweight with central obesity. We used Cox proportional hazards models to estimate HRs and 95% CIs. Results: The mean follow-up period was 8.8 y. Compared with participants with normal weight and WC, men who were overweight and centrally obese had higher cancer incidence risk at 3 sites [stomach (HR: 1.75; 95% CI: 1.33, 2.32; Padj = 0.002), kidney (HR: 1.45; 95% CI: 1.17, 1.81; Padj = 0.016), and colorectal (HR: 1.31; 95% CI: 1.17, 1.47; Padj < 0.001) cancer]. Similar associations were found at 4 sites in women [endometrial (HR: 2.48; 95% CI: 2.06, 2.98; Padj < 0.001), uterine (HR: 2.23; 95% CI: 1.89, 2.64; Padj < 0.001), kidney (HR: 1.84; 95% CI: 1.37, 2.46; Padj = 0.001), and breast (HR: 1.24; 95% CI: 1.16, 1.32; Padj < 0.001) cancer] and for all-cause cancer (HR: 1.07; 95% CI: 1.03, 1.10; Padj = 0.003). Only endometrial cancer mortality (HR: 3.28; 95% CI: 1.77, 6.07; Padj = 0.004) was significantly associated with being overweight and centrally obese. Conclusions: The combination of general and central obesity was associated with a higher risk at several cancer sites and some associations were sex-specific.es_CL
dc.language.isoenes_CL
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
dc.sourceThe American Journal of Clinical Nutrition, 113(2), 401-409es_CL
dc.subjectBody mass indexes_CL
dc.subjectWaist circumferencees_CL
dc.subjectCanceres_CL
dc.subjectObesityes_CL
dc.subjectSexes_CL
dc.titleCombined association of general and central obesity with incidence and mortality of cancers in 22 siteses_CL
dc.typeArticlees_CL
dc.ucm.indexacionScopuses_CL
dc.ucm.indexacionIsies_CL
dc.ucm.urisibib2.ucm.cl:2048/login?url=https://academic.oup.com/ajcn/article-abstract/113/2/401/6056217?redirectedFrom=fulltextes_CL
dc.ucm.doidoi.org/10.1093/ajcn/nqaa335es_CL


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 Chile
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 Chile